- Home
- LEGN
as of 11-13-2026 3:37pm EST
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.6B | IPO Year: | 2020 |
| Target Price: | $42.46 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $16.24 - $37.50 | Next Earning Date: | 11-10-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 38.71% | Revenue Growth (next year): | 18.83% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Legend Biotech Corporation (LEGN)
Director
Avg Cost/Share
$9.46
Shares
27,370
Total Value
$258,920.20
Owned After
52,731
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$9.14
Shares
5,430
Total Value
$49,630.20
Owned After
14,246
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | LEGN | Director | Sep 29, 2026 | Sell | $9.46 | 27,370 | $258,920.20 | 52,731 | |
| Santos Carlos E | LEGN | Chief Financial Officer | Sep 21, 2026 | Sell | $9.14 | 5,430 | $49,630.20 | 14,246 |
Compare LEGN vs Leading Stocks
See how LEGN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LEGN Legend Biotech Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.